Loading...

TerrAscend Corp.

TRSSF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.72
$-0.23(-11.79%)

TerrAscend Corp. (TRSSF) Stock Overview

Explore TerrAscend Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap601.9M
P/E Ratio-8.14
EPS (TTM)$-1.30
ROE-0.32%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.67

TRSSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TerrAscend Corp. (TRSSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.14 and a market capitalization of 601.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;